A decade ago, most investors had never heard of the term "litigation finance". Today, institutional capital treats it as a recognized alternative asset class.
A 2023 GAO report on the industry found nearly $12.4 billion in assets among the largest U.S. commercial litigation funders alone, and that figure has only grown since.
The appeal is straightforward. Litigation finance provides capital against a legal claim's likely outcome, and repayment depends entirely on the result.
Investors like this structure because legal outcomes do not move with stock prices or interest rates.
Individuals facing a pending legal claim like this structure it for a different reason. It gives them access to funds without having to repay anything if their case doesn't succeed.
Both groups are participating in the same underlying mechanism. Understanding how it works from an institutional perspective helps explain why it has become a practical option for individuals as well.
Pension funds, hedge funds, insurance companies, and family offices have moved into litigation finance for a reason that shows up in every allocator's playbook: diversification. A portfolio holding only stocks and bonds moves with the broader economy. Litigation finance does not.
A lawsuit resolves based on evidence, legal arguments, and settlement negotiations, not on interest rate decisions or earnings reports. That independence from macroeconomic cycles is exactly what large investors look for when markets get volatile.
Litigation finance also has a non-recourse structure at its core: the capital provider recovers its investment only if the underlying case succeeds, which forces funders to underwrite claims carefully rather than deploy capital indiscriminately.
Regulatory clarity has further accelerated this shift. Courts and legislatures in several jurisdictions have introduced disclosure rules for third-party funding agreements, which has, somewhat counterintuitively, increased investor confidence rather than slowed adoption.
Clearer rules mean funders can underwrite with more predictable assumptions, and predictable assumptions attract larger pools of capital.
Rising litigation costs play a role too. Discovery, expert witnesses, and courts that take longer to schedule hearings have driven up the cost of pursuing a legal claim across nearly every case type.
That cost pressure creates the exact conditions that institutional capital looks for: a large and growing pool of claimants who need financing to see a case through, and a funding model that pays out only when the underlying claim succeeds.
Strip away the fund structures and institutional due diligence, and the mechanism driving this asset class is identical to what an individual plaintiff encounters while waiting on a personal injury claim.
A plaintiff with a strong case and a slow-moving lawsuit faces the same basic problem an institutional investor solves for: money that will likely arrive eventually is not the same as money available now.
Medical bills, lost wages, and everyday expenses do not pause just because a case sits in negotiation or discovery. Meanwhile, banks and credit unions generally will not lend against a claim still working through the courts, since there is no collateral to secure and no fixed timeline for resolution.
That gap between "money that is likely coming" and "money in hand" is precisely what litigation finance closes for institutions and individuals alike. The scale differs.
A commercial funder might deploy several million dollars into a portfolio of corporate disputes, while an individual might access a few thousand dollars against a single personal injury claim.
The underlying logic stays the same: a funder advances capital against a probable legal outcome and recovers it only if that outcome materializes.
For an individual, funding for pending legal claims typically works as a non-recourse cash advance rather than a conventional loan. The plaintiff receives an amount tied to their case's likely value, and the provider recovers its advance, plus a fee, only if the case resolves favorably. If the claim does not succeed, the plaintiff owes nothing.
This structure removes several barriers to accessing traditional credit. Approval depends on the strength and value of the underlying claim rather than the applicant's credit score or income history, so a plaintiff whose injury has limited their ability to earn can still qualify for funding connected to their case.
There are also no monthly payments to manage while the case works through the legal system, since repayment happens once, at resolution, not on a recurring schedule.
The trade-off mirrors what institutional investors accept when they fund litigation: the cost of capital runs higher than conventional lending because the provider absorbs the risk of an unfavorable outcome. That risk premium is the price of a repayment structure that does not create financial pressure while a case is still pending.
Before pursuing litigation finance, an individual should weigh a few factors in light of their specific situation.
Cost Relative to Traditional Credit: A cash advance against a pending claim typically costs more than a personal loan or credit card, since the provider absorbs the risk of an unfavorable outcome. Compare that cost to the settlement amount remaining after fees.
Alternatives That Do Not Involve New Debt: Personal savings, family assistance, and payment deferral arrangements with medical providers or creditors may cost less. Each comes with its own trade-off: family assistance can strain relationships, savings can run out, and negotiating with a creditor takes effort.
Timing of the Decision: Plaintiffs who research funding early, before financial pressure builds, can compare providers and terms with a clear head. Those who wait until bills are overdue often accept the first offer available, sometimes on worse terms than they would have found with more time to shop around.
The right answer depends on how much runway a plaintiff has left and how much longer their case is likely to take. Neither of those numbers is ever perfectly predictable, which is exactly why understanding the option ahead of time matters more than reacting to it under pressure.
Litigation finance has moved from a niche legal-industry tool into a recognized alternative asset class, and the same non-recourse structure that attracts institutional capital is now accessible to individuals navigating their own pending legal claims.
The mechanics stay consistent across both ends of the market: a funder advances capital against a probable outcome and recovers it only if that outcome arrives.
For an individual plaintiff, knowing this option exists before a case drags on for months or years turns a potential financial crisis into a manageable bridge. The best time to understand your funding options is before you need them, and not after the bills start piling up.